A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

Findings could improve screening and treatment for patients of African ancestry HEALTH REPORT | THE INDEPENDENT & AGENCIES | ...

Sansum Clinic and Ridley-Tree Cancer Center will share a panel discussion that was presented on prostate health. To view the video presentation, click ...

Dr. Kurt N. Ransohoff, President, Sutter Health Greater Central Coast, moderated the multidisciplinary panel of six ...

A set of genes may identify a prostate cancer subtype in African American patients that needs aggressive treatment. Specific genes may signal aggressive prostate cancer (PCa) in African American men, ...

A study of three genes associated with the development of prostate cancer found that men with inherited mutations in these genes are more likely to develop aggressive forms of the disease and die from ...

Many clinicians who treat men with prostate cancer may be unfamiliar with the term "treatment-emergent small-cell neuroendocrine prostate cancer" (t-SCNC). That's because it has been considered a rare ...